OCULAR THERAPEUTIX, INC·4

Feb 13, 8:36 PM ET

Notman Donald 4

4 · OCULAR THERAPEUTIX, INC · Filed Feb 13, 2025

Insider Transaction Report

Form 4
Period: 2025-02-11
Notman Donald
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-02-11+115,000308,444 total
  • Award

    Stock Option (Right to Buy)

    2025-02-11+344,115344,115 total
    Exercise: $7.44Exp: 2035-02-10Common Stock (344,115 underlying)
Footnotes (2)
  • [F1]On February 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
  • [F2]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.

Documents

1 file
  • 4
    tm256513-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT